Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adenocarcinoma × Ramucirumab × Clear all

Phase

Status

Completed 5 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 4 Esophageal Neoplasms 3 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma Of Esophagus 2 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Metastatic Small Intestinal Adenocarcinoma 1 Head and Neck Neoplasms 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 Colorectal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 8 Oxaliplatin 8 Fluorouracil 7 Leucovorin 6 Gemcitabine 5 Docetaxel 5 cemiplimab 4 Blood Specimen Collection 4 zolbetuximab 3 Taxes 3 Radiotherapy 3 Paclitaxel 3 Nivolumab 3 Cyclophosphamide 3 Capecitabine 3 trastuzumab deruxtecan 2 fludarabine 2 enzalutamide 2 durvalumab 2 darolutamide 2 alpha-2'-deoxythioguanosine 2 Trastuzumab 2 Standard of Care 2 Radiosurgery 2 Irinotecan 2 Folfox protocol 2 Dexamethasone 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04069273 2025-07-31

SEQUEL

Hoosier Cancer Research Network

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡